Cost-effective screening for cerebral aneurysms.
The advent of accurate, noninvasive angiography has raised hopes that premorbid screening for cerebral aneurysm will soon be possible. This article discusses the medical and economic issues which will determine the appropriate conditions for, and cost-effectiveness of, large-scale aneurysm screening.
Alterman
R L
RL
Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, USA.
Drucker
E
E
D002533:Cerebral Angiography / Q000191:economics*; D003362:Cost-Benefit Analysis; D003399:Craniotomy / Q000191:economics; D018450:Disease Progression; D005192:Family Health; D006801:Humans; D002532:Intracranial Aneurysm / Q000191:economics* / Q000503:physiopathology / Q000517:prevention & control / Q000601:surgery; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D018803:Models, Economic; D018579:Patient Selection; D012307:Risk Factors; D013345:Subarachnoid Hemorrhage / Q000191:economics* / Q000503:physiopathology / Q000517:prevention & control / Q000601:surgery; D014481:United States